Cleared Traditional

MyKnee UNI-ST (K231037) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K231037 · Medacta International S.A. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2023
Decision
58d
Days
Class 2
Risk

K231037 is an FDA 510(k) clearance for the MyKnee UNI-ST. Classified as Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer/metal/polymer (product code JWH), Class II - Special Controls.

Submitted by Medacta International S.A. (Castel San Pietro, CH). The FDA issued a Cleared decision on June 9, 2023 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3560 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medacta International S.A. devices

Submission Details

510(k) Number K231037 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 12, 2023
Decision Date June 09, 2023
Days to Decision 58 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
64d faster than avg
Panel avg: 122d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JWH Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer/metal/polymer
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Medacta USA
Lussier Christopher

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - JWH Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer/metal/polymer

All 516
Devices cleared under the same product code (JWH) and FDA review panel - the closest regulatory comparables to K231037.
Klassic® Tibial Insert, PS-Post, Klassic All Poly Tibia, PS-Post
K232414 · Total Joint Othopedics, Inc. · Sep 2023
TRULIANT® E-PX Tibial Inserts
K223252 · Exactech, Inc. · Jul 2023
iTotal Identity Knee Replacement System
K230846 · Conformis, Inc. · Jul 2023
Triathlon® Total Knee System - Triathlon® Pro Posterior Stabilized (PS) Femoral Component
K230952 · Howmedica Osteonics Corp., Dba Stryker Orthopaedics · Jun 2023
Identity™ Imprint™ CR KRS and Identity™ Imprint™ PS KRS
K231233 · Conformis, Inc. · May 2023
Klassic Knee Revision System
K230537 · Total Joint Othopedics, Inc. · May 2023